Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_assertion description "[Well designed clinical studies performed in patients with CF and mild to moderate pulmonary disease [forced vital capacity (FVC) > or = 40% of predicted value] show that aerosolised dornase alfa improves lung function, achieving a 6 to 7% increase from baseline in forced expiratory volume in 1 second (FEV1) after 6 months' therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_assertion evidence source_evidence_literature NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_assertion SIO_000772 7533697 NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_assertion wasDerivedFrom befree-20140225 NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_assertion wasGeneratedBy ECO_0000203 NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP384873.RAWEfBkPPw6u-KRMw2hm0DNwd5tEyRfB-Rp--vs2y2SEk130_provenance.